Cargando…

Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination

INTRODUCTION: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is one of several chronic treatable acquired demyelinating neuropathies. OBJECTIVES: To explore the association between the degree of demyelination in CIDP, and treatment responsiveness. METHODS: A retrospective chart rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abraham, Alon, Alabdali, Majed, Qrimli, Mohammad, Albulaihe, Hana, Breiner, Ari, Barnett, Carolina, Katzberg, Hans D., Lovblom, Leif E., Perkins, Bruce A., Bril, Vera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603787/ https://www.ncbi.nlm.nih.gov/pubmed/26461125 http://dx.doi.org/10.1371/journal.pone.0139674

Ejemplares similares

Elevated Vibration Perception Thresholds in CIDP Patients Indicate More Severe Neuropathy and Lower Treatment Response Rates
por: Abraham, Alon, et al.
Publicado: (2015)

Comparison of diabetes patients with “demyelinating” diabetic sensorimotor polyneuropathy to those diagnosed with CIDP
por: Dunnigan, Samantha K, et al.
Publicado: (2013)

The sensitivity and specificity of the neurological examination in polyneuropathy patients with clinical and electrophysiological correlations
por: Abraham, Alon, et al.
Publicado: (2017)

Laser Doppler Flare Imaging and Quantitative Thermal Thresholds Testing Performance in Small and Mixed Fiber Neuropathies
por: Abraham, Alon, et al.
Publicado: (2016)

Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes
por: Breiner, Ari, et al.
Publicado: (2019)

The Characteristics of Chronic Inflammatory Demyelinating Polyneuropathy in Patients with and without Diabetes – An Observational Study
por: Dunnigan, Samantha K., et al.
Publicado: (2014)

Treatment Approaches for Atypical CIDP
por: Menon, Deepak, et al.
Publicado: (2021)

Conduction Slowing in Diabetic Sensorimotor Polyneuropathy
por: Dunnigan, Samantha K., et al.
Publicado: (2013)

Evaluation of Proxy Tests for SFSN: Evidence for Mixed Small and Large Fiber Dysfunction
por: Ebadi, Hamid, et al.
Publicado: (2012)

Measurement of Cooling Detection Thresholds for Identification of Diabetic Sensorimotor Polyneuropathy in Type 1 Diabetes
por: Lysy, Zoe, et al.
Publicado: (2014)

Electrophysiological Responsiveness to Long-Term Therapy in Chronic Inflammatory Demyelinating Polyneuropathy: Case Report
por: Khomand, Payam, et al.
Publicado: (2020)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): An Uncommon Manifestation of Systemic Lupus Erythematosus (SLE)
por: Abraham, Hrudya, et al.
Publicado: (2017)

Systematic Comparison of Muscle Ultrasound Thickness in Polyneuropathies and Other Neuromuscular Diseases
por: Alnajjar, Sara A., et al.
Publicado: (2023)

Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP)
por: Joshi, Abhijeet R., et al.
Publicado: (2016)

Abnormality of multimodal evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
por: Dziadkowiak, Edyta, et al.
Publicado: (2020)

Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)

Temporal Dispersion and Duration of the Distal Compound Muscle Action Potential Do Not Distinguish Diabetic Sensorimotor Polyneuropathy From Chronic Inflammatory Demyelinating Polyneuropathy
por: Alcantara, Monica, et al.
Publicado: (2022)

Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern
por: Eftimov, Filip, et al.
Publicado: (2014)

CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS
por: Capodivento, Giovanna, et al.
Publicado: (2021)

Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)
por: Querol, Luis, et al.
Publicado: (2020)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Diabetes Mellitus: A Diagnostic Dilemma
por: Valentin, Marcos, et al.
Publicado: (2022)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Overview, Treatment, and a Case Study
por: Ponnala, Madhusudhan, et al.
Publicado: (2023)

Reliability and Validity of a Point-of-Care Sural Nerve Conduction Device for Identification of Diabetic Neuropathy
por: Lee, Justin A., et al.
Publicado: (2014)

Conductive hearing loss in chronic inflammatory demyelinating polyneuropathy (CIDP): A case report
por: Fadel, Mark A., et al.
Publicado: (2018)

Identification and Prediction of Diabetic Sensorimotor Polyneuropathy Using Individual and Simple Combinations of Nerve Conduction Study Parameters
por: Weisman, Alanna, et al.
Publicado: (2013)

Structure-Function Relationship Between Corneal Nerves and Conventional Small-Fiber Tests in Type 1 Diabetes
por: Sivaskandarajah, Gavasker A., et al.
Publicado: (2013)

Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study
por: Barnett, Carolina, et al.
Publicado: (2014)

Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale
por: Barnett, Carolina, et al.
Publicado: (2015)

The comparison of MRN, electrophysiology and progression among typical CIDP and atypical CIDP subtypes
por: Feng, Yuan, et al.
Publicado: (2020)

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
por: Blackhouse, Gord, et al.
Publicado: (2010)

Can Ultrasound of the Tibial Nerve Detect Diabetic Peripheral Neuropathy?: A cross-sectional study
por: Riazi, Sheila, et al.
Publicado: (2012)

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
por: Merkies, Ingemar S.J., et al.
Publicado: (2019)

Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins
por: Ritter, Christian, et al.
Publicado: (2015)

The Misdiagnosis of CIDP: A Review
por: Allen, Jeffrey A.
Publicado: (2020)

Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study
por: van Schaik, Ivo N., et al.
Publicado: (2019)

Using in vivo corneal confocal microscopy to identify diabetic sensorimotor polyneuropathy risk profiles in patients with type 1 diabetes
por: Lewis, Evan J H, et al.
Publicado: (2017)

Severe CIDP-MGUS responsive to Rituximab
por: Posa, Andreas, et al.
Publicado: (2020)

CIDP mimics: a case series
por: Moshe-Lilie, Orly, et al.
Publicado: (2021)

Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept study
por: Masanneck, Lars, et al.
Publicado: (2023)

MRI biomarkers of proximal nerve injury in CIDP
por: Lichtenstein, Thorsten, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9ji2fk7kd1cqs9d4rvhe2p9r8d